2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine, 98%, 250mg

Ethyl 5-tert-butylisoxazole-3-carboxylate, 95.0%, 5g

Methyl 5-fluoro-2-iodobenzoate, 95.0%, 10g

2-Bromo-5,6-dihydro-4H-pyrazolo[1,5-d][1,4]diazepin-7(8H)-one, 98%, 250mg

8-Iodoisoquinoline, 95.0%, 250mg

Headspace vials ROTILABO® with beaded rim ND20 flat Headspace bottom, DIN rolled edge, not suitable for overpressure, 100 ml, 88 Piece(s)

2,5-Dibromo-1,1,3,4-tetraphenylsilole>98.0%(GC)1g

4-Bromo-3,5-dichlorobenzoic acid, 95.0%, 1g

N-Phthaloylglycine, 95.0%, 100g

2-(4-Isobutoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

4,4,5,5-Tetramethyl-2-(phenoxathiin-4-yl)-1,3,2-dioxaborolane, 98%, 1g

tert-Butyl 6-nitro-1H-indazole-1-carboxylate, 95.0%, 1g

(R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid, 95.0%, 25g